OVERACTIVE BLADDER IN WOMEN WITH GENITAL PROLAPSE DURING MENOPAUSE
https://doi.org/10.21518/2079-701X-2017-2-128-131
Abstract
Epidemiological studies showed that overactive bladder (OAB) syndrome is among the ten most common diseases, ahead of diabetes, gastric ulcer and duodenal ulcer. In addition, the number of patients with OAB is steadily growing every year. Prevalence of OAB ranges from 12 to 22%, and despite a significant decline in the quality of life, only 4–6,2% of patients seek the help of professionals.
About the Authors
A. G. Imelbayeva
Bashkir State Medical University, Russia’s Ministry of Health
Russian Federation
Russian Federation
A. G. Yaschuk
Bashkir State Medical University, Russia’s Ministry of Health
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
I. I. Musin
Bashkir State Medical University, Russia’s Ministry of Health
Russian Federation
Russian Federation
References
1. Hullfish K, Fenner D, Sorser SA, Visger J, Clayton A, Steers WD. Postpartum depression, urge urinary incontinence, and overactive bladder syndrome: Is there an association? Int Urogynecol J Pelvic Floor Dysfunct, 2007, 18: 1121-1126.
2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn, 2010, 29(1): 4-20.
3. Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: A population-based study in Finland. Am J Obstet Gynecol, 2008, 199(153): e1-12.
4. Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial. Am J Obstet Gynecol, 2006, 195: 1730-1735.
5. Кулаков В.И., Аполихина И.А., Деев А.Д. Акушерско-гинекологические факторы риска недержания мочи у женщин. Акушерство и гинекология, 2005, 3: 32-36.
6. Hashim H, Abrams P. Is the bladder an unreliable witness for predicting detrusor overactivity? J Urol, 2006, 175: 191-194.
7. Waetjen LE, Feng WY, Ye J, Johnson WO, Greendale GA, Sampselle CM, Sternfield B, Harlow SD, Gold EB. Factors associated with worsening and improving urinary incontinence across the menopausal transition. Obstetrics and Gynecology, 2008, 111: 667-677.
8. Краснопольский В.И., Буянова С.Н., Петрова В.Д. Диагностика типов недер жание мочи у женщин при пролапсе гениталий. Вестник, 1999, 3: 53-56.
9. Oelke V, Khullar H. Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials. World J Urol, 2013, 31: 1093-1094.
Review
For citations:
Imelbayeva AG, Yaschuk AG, Musin II. OVERACTIVE BLADDER IN WOMEN WITH GENITAL PROLAPSE DURING MENOPAUSE. Meditsinskiy sovet = Medical Council. 2017;(2):128-131. (In Russ.) https://doi.org/10.21518/2079-701X-2017-2-128-131
Views:
567
Email this article 